How to develop next-generation SARS-CoV-2 immunotherapies at “pandemic pace”
Discover how a Canadian biotechnology company uses flow cytometry to facilitate the generation of high-affinity antibodies against infectious disease.
Discover how a Canadian biotechnology company uses flow cytometry to facilitate the generation of high-affinity antibodies against infectious disease.
Increased sample throughput and consistency in COVID-19 and other swab-based tests is supported through use of the novel RHINOstic Automated Nasal Swab
Watch leading scientists online, February 15, to discover the latest analytical tools and techniques for life sciences, biopharma, materials and more
The collaboration aims to create one of the world’s largest organizations dedicated to diagnostics and laboratory informatics
Claim your free compilation of top eBooks, articles, techniques, webinars and videos from our scientific communities
Collaboration extends global reach for Thermo Fisher’s rapid next-generation sequencing technology
Study findings add to the evidence that vaccination during pregnancy does not increase the risk of complications in pregnancy but COVID-19 does
Explore how a partnership between a lead researcher in sexual health and a molecular diagnostics innovator helped to overcome the therapeutic hurdles that come with antibiotic resistance
The partnership aims to combine oncolytic viruses with Affibody® molecules
Discover the latest tools and techniques to advance your work with lessons from leading experts on therapeutic proteins, 3D disease models, clinical analysis, and more
Watch this on-demand webinar to learn more about the potential consequences of SARS-CoV-2 mutations and variants for vaccination status and lab testing
Watch this on-demand webinar to find out the advantages of immunotyping over immunofixation in detecting M-proteins
Dr. Tania Nolan reveals the challenges of flu season uncertainty amid the COVID-19 pandemic and where combo testing could fit in
Study shows people with severe mental illnesses experience significantly poorer outcomes resulting from COVID-19 which are only partly explained by pre-existing physical health conditions
Find out how unbiased lab product reviews are changing the world of science - and why not get involved yourself?
SpaceX’s successful Crew-3 launch carried devices to help NASA researchers sample astronauts aboard the ISS to better understand human health in space
Discover the latest resources and innovative tools driving immuno-oncology research forward
Discover insights on topics from lab automation and gene therapy to monoclonal antibodies and clinical diagnostics
Company testing three existing COVID-19 vaccine booster candidates against the Omicron variant